化合物Multi-kinase inhibitor I T4191
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
50 mg | 778274-97-8 | ¥3,920.00 | 询底价 |
10 mg | 778274-97-8 | ¥1,230.00 | 询底价 |
25 mg | 778274-97-8 | ¥2,490.00 | 询底价 |
5 mg | 778274-97-8 | ¥788.00 | 询底价 |
1 mg | 778274-97-8 | ¥312.00 | 询底价 |
1 mL | 778274-97-8 | ¥927.00 | 询底价 |
100 mg | 778274-97-8 | ¥5,580.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Multi-kinase inhibitor 1
描述: Multi-kinase inhibitor 1 (Multi-kinase inhibitor I) 是多激酶抑制剂。它有用于导致与酪氨酸激酶活性异常或失控有关的疾病或失调的潜力,特别是与c-Kit,PDGF-R,Bcr-abl 活性相关的疾病。
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 55 mg/mL (131.46 mM)
关键字: Platelet-derived growth factor receptor | inhibit | Bcr-Abl | SCFR | CD117 | c-Kit | Multi-kinase inhibitor 1 | Multi kinase inhibitor 1 | PDGFR | Multikinase inhibitor 1 | Inhibitor
相关产品: BCR-ABL-IN-1 | Vodobatinib | Rigosertib | PD180970 | PHA-665752 | ON 146040 | PPY A | Danusertib | Gypsogenin | Ponatinib
相关库: Anti-Cancer Compound Library | Cytokine Inhibitor Library | Membrane Protein-targeted Compound Library | Anti-Lung Cancer Compound Library | Fluorochemical Library | Kinase Inhibitor Library | Inhibitor Library | Cytoskeletal Signaling Pathway Compound Library | Tyrosine Kinase Inhibitor Library | Bioactive Compound Library
化合物Multi-kinase inhibitor I T4191信息由TargetMol中国为您提供,如您想了解更多关于化合物Multi-kinase inhibitor I T4191报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途